The price of Invokamet varies depending on factors such as dosage, quantity, and insurance coverage. For example, a 30-day supply of Invokamet XR 290-15 mg tablets can range from approximately $500 to over $600 without insurance [1]. Discounts and savings cards may be available, potentially lowering the out-of-pocket cost [1].
What influences the cost of Invokamet?
Several elements affect the retail price of Invokamet. The specific formulation, such as immediate-release or extended-release (XR), and the strength of the medication (e.g., 50-500 mg, 150-1000 mg, or 290-15 mg for XR) will influence the cost. The number of tablets in a prescription also directly impacts the total price. Additionally, pharmacy pricing strategies and the availability of generic alternatives can play a role [1].
Are there ways to get Invokamet for less?
Patients may find ways to reduce the cost of Invokamet. Pharmaceutical companies often offer patient assistance programs or savings cards for eligible individuals. Comparing prices across different pharmacies can also reveal savings opportunities. If a generic version becomes available, it typically offers a lower price point than the branded medication [1].
When does Invokamet's patent protection end?
Invokamet is a combination drug containing canagliflozin and metformin. The patent status of these individual components and the combination product itself determines when generic versions can be legally marketed. Information on the specific patent expiration dates for Invokamet and its active ingredients can be found through specialized drug patent databases, such as DrugPatentWatch.com [2].
Who makes Invokamet?
Invokamet is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [3]. Janssen is responsible for the development, marketing, and distribution of the drug.
How does Invokamet work for type 2 diabetes?
Invokamet combines two active ingredients to manage type 2 diabetes. Canagliflozin belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. It works by blocking the reabsorption of glucose in the kidneys, causing excess glucose to be excreted in the urine. Metformin is a biguanide that reduces the amount of glucose produced by the liver and improves the body's sensitivity to insulin [4].
What are the alternatives to Invokamet?
Various other medications are available for managing type 2 diabetes, offering different mechanisms of action and potential benefits. These include other SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 receptor agonists, sulfonylureas, and insulin. The choice of alternative depends on individual patient needs, existing medical conditions, and treatment goals [4].
Sources:
[1] https://www.goodrx.com/invokamet
[2] https://drugpatentwatch.com/
[3] https://www.janssen.com/
[4] https://www.webmd.com/drugs/2/drug-81478/invokamet-oral